C. Fagnoni-Legat

Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.

X. Pivot, C. Borg, M. Demarchi, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

C. Borg, E. Kalbacher, F. Ghiringhelli, 2022, Frontiers in Oncology.

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study

C. Mascaux, C. Borg, D. Vernerey, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathy.

A. Gauthier, C. André, C. Fagnoni-Legat, 2022, Journal francais d'ophtalmologie.

Computerized prescribing of standardized chemotherapy schedules: residual medication errors and pharmaceutical interventions.

M. Woronoff-lemsi, L. Chaigneau, S. Limat, 2006 .

[Galenic and analytic development of tacrolimus 0.06% eye drops].

B. Delbosc, A. Gauthier, S. Limat, 2013, Journal francais d'ophtalmologie.

Efficacy of trabectedin in metastatic solitary fibrous tumor

X. Pivot, E. Kalbacher, A. Thiery-Vuillemin, 2011, Rare tumors.

ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature

A. Louvrier, I. Madelaine, S. Limat, 2021, Frontiers in Medicine.

Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs.

D. Mazel, D. Hocquet, X. Bertrand, 2019, The Journal of antimicrobial chemotherapy.